期刊文献+

辛伐他汀上调肾小管上皮细胞ADAMTS13 mRNA表达

Simvastatin upregulates ADAMTS13 mRNA expression in human renal tubular epithelial cell line HK-2
原文传递
导出
摘要 目的观察不同细胞因子对近端肾小管上皮细胞株(HK-2)血管性血友病因子裂解酶(ADAMTS13)的影响及辛伐他汀干预结果。方法炎症因子按浓度分组:TNF-α0、0.1、1、10ng/ml分为A0-A3组;IL-6 0、1、10、100ng/ml分为B0-B3组;IL-4 0、1、5、10ng/ml分为C0-C3组。辛伐他汀0、0.1、1、10μmol/L分为D0-D3组。两者共培养分成不同浓度辛伐他汀+TNF-α10ng/ml(E0-E3)组,不同浓度辛伐他汀+IL-6 100ng/ml(F0-F3)组和不同浓度辛伐他汀+IL-4 10ng/ml(G0-G3)组。孵育HK-2 24h,用实时定量PCR法和Western blot法检测ADAMTS13的mRNA及蛋白表达水平,结果与各组的0组相比较。结果 A组和B组ADAMTS13mRNA表达水平呈剂量依赖性下降(P<0.05或P<0.01)。与D0组比较,ADAMTS13 mRNA表达水平在D1组下降(P<0.05),在D3组上升(P<0.01)。E、F组ADAMTS13mRNA表达呈辛伐他汀浓度依赖性增加(P<0.05或P<0.01)。结论不同的炎症因子对HK-2上ADAMTS13的表达、合成、分泌起到不同的作用,提示与肾脏局部微循环障碍有关。而辛伐他汀能在存在炎症因子的条件下提高肾小管上皮细胞ADAMTS13的表达。 Objective To investigate the effects of inflammatory cytokines on ADAMTS13 expression in human proximal tubular epithelial cell line(HK-2)and the intervention of simvastatin on it.Methods According to different concentrations,TNF-α0,0.1,1,and 10ng/ml were as groups of A0-A3,IL-6 0,1,10 and 100ng/ml were as groups of B0-B3,IL-4 0,1,5and 10ng/ml were as groups of C0-C3,simvastatin 0,0.1,1and 10μmol/L were as groups of D0-D3.Simvastatin in different concentrations was cocultured with TNF-α10ng/ml(groups of E0-E3),with IL-6 100ng/ml(groups of F0-F3),and with IL-4 10ng/ml(groups of G0-G3).After cultured with HK-2for 24 hours,ADAMTS13mRNA expressions in HK-2were detected by RT-PCR and ADAMTS13 protein levels were detected by Western blot.Results Compared to group 0,ADAMTS13 mRNA in the other TNF-αgroups and IL-6groups were decreased in a dose-dependent manner(P〈0.05 or P〈0.01).Compared with group D0,ADAMTS13 mRNA decreased in group D1,but increased in group D3(P〈0.01).ADAMTS13 mRNA expression in groups of E and F increased in a dose-dependent manner(P〈0.05 or P〈0.01).Conclusion Different inflammatory factors appeare to have different effects on the expression and secretion of ADAMTS13 in HK-2.Simvastatin increases ADAMTS13 mRNA expression in HK-2.
出处 《江苏医药》 CAS 2015年第1期14-17,共4页 Jiangsu Medical Journal
基金 苏州市科技项目(SYS201118)
关键词 辛伐他汀 肾小管上皮细胞 血管性血友病因子裂解酶 Simvastatin Renal tubular epithelial cell A disintegrin-like and metalloprotease with thrombospondin type 1 repeats 13
  • 相关文献

参考文献8

  • 1Claus RA,Bockmeyer CL,Budde U,et al.Variations in the ratio between von Willebrand factor and its cleaving protease during systemic inflammation and association with severity and prognosis of organ failure[J].Thromb Haemost,2009,101(2):239-247.
  • 2Martin K,Borgel D,Lerolle N,et al.Decreased ADAMTS-13(a disintegrin-like and metalloprotease with thrombospondin type 1repeats)is associated with a poor prognosis in sepsisinduced organ failure[J].Crit Care Med,2007,35(10):2375-2382.
  • 3Manea M,Tati R,Karlsson J,et al.Biologically active ADAMTS13is expressed in renal tubular epithelial cells[J].Pediatr Nephrol,2010,25(1):87-96.
  • 4马珍妮,董宁征,张敬宇,苏健,汪安友,阮长耿.血管性血友病因子裂解蛋白酶的稳定表达及其活性检测[J].生物工程学报,2010,26(2):244-248. 被引量:6
  • 5Shen L,Lu GY,Dong NZ,et al.Von Willebrand factor,ADAMTS13activity,TNF-alpha and their relationships in patients with chronic kidney disease[J].Exp Ther Med,2012,3(3):530-534.
  • 6Zager RA,Johnson A.Renal cortical cholesterol accumulation is an integral component of the systemic stress response[J].Kidney Int,2001,60(6):2299-2310.
  • 7Zager RA,Johnson AC,Hanson SY.Sepsis syndrome stimulates proximal tubule cholesterol synthesis and suppresses the SR-B1cholesterol transporter[J].Kidney Int,2003,63(1):123-133.
  • 8Shen L,Lu G,Dong N,et al.Simvastatin increases ADAMTS13expression in podocytes[J].Thromb Res,2013,132(1):94-99.

二级参考文献11

  • 1Dong JF. Structural and functional correlation of ADAMTS13. Curt Opin Hematol, 2007, 14(3): 270-276.
  • 2Bergmeier W, Chauhan AK, Wagner DD. Glycoprotein Ibalpha and von Willebrand factor in primary platelet adhesion and thrombus formation: lessons from mutant mice. Thromb Haemost, 2008, 99(2): 264-270.
  • 3Tsai HM. Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiency.Hematol Oncol Clin North Am, 2007, 21(4): 609-632.
  • 4Zheng XL, Sadler JE. Pathogenesis of thrombotic microangiopathies. Annu Rev Pathol, 2008, 3: 249-277.
  • 5Desch KC, Motto DG. Thrombotic thrombocytopenic purpura in humans and mice. Arterioscler Thromb Vasc Biol, 2007, 27(9): 1901-1908.
  • 6Levy GG, Nichols WC, Lian EC, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature, 2001, 413(6855): 488-494.
  • 7Tsai HM. Current concepts in thrombotic thrombocytopenic purpura. Annu Rev Med, 2006, 57: 419-436.
  • 8Tao Z, Peny Y, Nolasco L, et al. Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWFstrings by ADAMTS13 under flow conditions. Blood, 2005, 106(13): 4139-4145.
  • 9Zhou W, Tsai HM. An enzyme immunoassay of ADAMTS13 distinguishes patients with thrombotic thrombocytopenic purpura from normal individuals and carriers of ADAMTS 13 mutations. Thromb Haemost, 2004, 91(4): 806-811.
  • 10Tsai HM. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood, 1996, 87(10): 4235-4244.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部